je.st
news
Tag: presentation
City Council Presentation
2013-06-13 00:16:56| PortlandOnline
On June 12, 2013 City Council heard the Ordinance to Adopt the Civil Rights Title VI Plan PDF Document, 12,394kbCategory: Civil Rights - Title VI
Tags: city
council
presentation
city council
Cimatron Chosen for Special Presentation at Amerimold
2013-06-06 06:00:00| Industrial Newsroom - All News for Today
Cimatron Technologies' VP Sales to present, "Six mold design best practices"<br /> <br /> GIVAT SHMUEL, Israel – Cimatron Limited, <a href="http://www.cimatron.com">http://www.cimatron.com</a> , (NASDAQ: CIMT) today announced that the latest version of its integrated CAD/CAM software, CimatronE 11, will be demonstrated at the Amerimold trade show in Rosemont, IL, June 12-13, 2013. The show will also feature a special presentation from Cimatron as part of the Amerimold "Knowledge Centers" ...This story is related to the following:CAD/CAM Software
Tags: special
presentation
chosen
cimatron
CytRx Announces the Presentation of Favorable Results from Novel...
2013-06-04 14:05:23| Logistics - Topix.net
CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, announced that preliminary results from a Phase 1b clinical trial determined that aldoxorubicin, the Company's improved version of the widely used chemotherapeutic agent doxorubicin, administered at 90% of its single agent dose can be safely delivered ... (more)
Tags: results
presentation
novel
favorable
Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013
2013-06-02 17:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. -Merck Expands Lambrolizumab Clinical Development Program- -Study Published Online in the New England Journal of Medicine- WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of preliminary results from an ongoing Phase IB expansion study evaluating the safety and efficacy of lambrolizumab (MK-3475), Mercks investigational antibody therapy targeting PD-1, in patients with advanced (inoperable and metastatic) melanoma. Language: English Contact HTML: MerckMedia Contacts:Ian McConnell, 973-901-5722Cathy Cantone, 908-327-3013orInvestor Contacts:Carol Ferguson, 908-500-1101Justin Holko, 609-915-8293 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
study
presentation
Sharing Ideas presentation -- Thursday, June 13th
2013-05-31 20:19:27| PortlandOnline
Community Legacy Program of Our United Villages invites you to the next presentation of Sharing Ideas on Thursday, June 13th, 2013 at Central Northeast Neighbors (4415 NE 87th Portland, Oregon 97220) from 6:00 8:00 PM. Sharing Ideas showcases the positive efforts of neighbors, groups and organizations throughout Portland.
Tags: june
thursday
ideas
presentation
Sites : [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] next »